ACCURUS 200
Report
- Report Number
- 2028159-2008-00160
- Event Type
- Injury
- Date Received
- May 8, 2008
- Date of Event
- March 10, 2008
- Report Date
- April 7, 2008
- Manufacturer
- ALCON - IRVINE TECHNOLOGY CENTER
- Product Code
- HQC
- PMA / PMN Number
- K911808
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEPARTMENT OF OPHTHALMOLOGY'S REPORT FOR "POSTOPERATIVE ENDOPHTHALMITIS, A GUIDE TO DIAGNOSIS & TREATMENT" AND QUESTIONS TO DETERMINE IF CLEANING AND DIRECTIONS FOR USE INFO WERE ADDRESSED WITH THE FACILITY, BUT NO RESPONSE WAS NOTED. THE SURGEON SUSPECTS OTHER INSTRUMENTS IN THE OCCURRENCE OF THESE INFECTIONS. THE ROOT CAUSE OF THE REPORTED CASE OF ENDOPHTHALMITIS CANNOT BE DETERMINED IN THIS INVESTIGATION. THERE IS ONE ADDITIONAL COMPLAINT RELATED TO THE REPORTED EVENT AND IT IS FROM THE SAME FACILITY, THE SAME CONSOLE, BUT A DIFFERENT PT. A REVIEW OF COMPLAINT TREND INDICATES NO ADVERSE TRENDS FOR THE REPORTED COMPLAINT. ADDITIONAL INFO RECEIVED STATED THE SYSTEM IS STILL USED WITHOUT PROBLEM. NO OTHER CASE OF ENDOPHTHALMITIS HAS BEEN REPORTED. ALL THE FACILITY'S PROCEDURES REGARDING THE CLEANING AND THE STERILIZATION HAVE BEEN REVIEWED BUT NOTHING WAS FOUND OUT OF COMPLIANCE. THIS REPORT MAILED IN TO FDA ON: 05/07/2008.
THE CUSTOMER REPORTED, TWO CASES OF ENDOPHTHALMITIS. THIS PT WAS DIAGNOSED THREE WEEKS POST-OP. THE PT WAS HOSPITALIZED FOR 9 DAYS. THE SURGEON COMPLETED A DOUBLE DISINFECTION WITH BETADINE (PROVIDONE-IODINE) ON THE EYE, EYELIDS AND FORNIX FOR TWO (2) TO THREE (3) MINUTES PRIOR TO SURGERY. DURING THE INITIAL SURGERY, A 3.2 MM TEMPORAL INCISION WAS COMPLETED. THE INCISION WAS SUTURED WITH ONE STITCH. THERE WERE GREY INFLAMMATORY DEPOSITS ON THE INTRAOCULAR LENS (IOL) NOTED AND ANTIBIOTICS WERE GIVEN. THE PT HAD PERIBULBAR ANAESTHESIA. POSTOPERATIVE, THE FOLLOWING TREATMENTS WERE PRESCRIBED: TOBRADEX, INDOCOLLYRE (INDOMETHACIN), MYDRIATICUM (TROPICAMIDE). NO ISSUE OCCURRED DURING SURGERY. ADDITIONAL INFO REC'D STATED THE PT REQUIRED UNPLANNED INTRAVENOUS ANTIBIOTHERAPY, INTRAVITREOUS INJECTION OF ANTIBIOTICS AND CORTICOIDS (SIC) AND LOCAL TREATMENT WITH ANTIBIOTICS, MYDRIATIC AND AN ANTI-INFLAMMATORY TO ADDRESS THE REPORTED EVENT. BACTERIOLOGIC CULTURE AND UNIVERSAL POLYMERASE CHAIN REACTION (PCR) WERE DONE TO THE AQUEOUS SAMPLE AND THE RESULTS WERE NEGATIVE. THE BALANCED SALT SOLUTION, WITH EPINEPHRINE, WAS CHANGED BETWEEN PROCEDURES, ALONG WITH THE IRRIGATION/ASPIRATION TIPS. THE CUSTOM PACK, IOL, AND VISCOELASTICS (TWINVISC) USED BY THE SURGEON WERE NOT ALCON PRODUCTS. THE PT OUTCOME WAS NOTED AS GOOD. ADDITIONAL INFO REC'D STATED THE PT TOTALLY RECOVERED WITHOUT SEQUELAE. THIS REPORT IS FOR ONE PT; FOR ADDITIONAL PT SEE MFG. REPORT # 2028159-2008-00161.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ACCURUS 200 | OPHTHALMIC SURGERY SYSTEM | HQC | ALCON - IRVINE TECHNOLOGY CENTER | ACCURUS 200 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Hospitalization| R | BSS WITH EPI| CUSTOM PACK| IOL| VISCOELASTICS |